Gut microbial metabolites such as trimethylamine N-oxide (TMAO), which are elevated in individuals with steatotic liver disease, promote lipid deposition in hepatocytes by increasing intestinal barrier permeability and activating the toll-like receptor 4 (TLR4)/NF-κβ pathway [67]. This evidence concerns the gene TLR4 and liver disorder.